A trial to detect behavioral changes by swimming stress

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 7, 1998, Pages 587-594

  Imaizumi, Masahiro ^a   Miyazaki, Shuichi ^b   Fushiki, Tohru ^a   Kim, Kyung Mi ^a   Onodera, Kenji ^c  

^a KYOTO UNIVERSITY   (Japan)

^b YAMASA CORPORATION   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Exercise; Light dark test; Runner's high; Stress; Swimming

Indexed keywords

NALOXONE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; BEHAVIOR; CONFERENCE PAPER; CONTROLLED STUDY; EXERCISE; FATIGUE; LIGHT DARK CYCLE; LOCOMOTION; MALE; MENTAL STRESS; MOUSE; NONHUMAN; PHYSICAL STRESS; REARING; SWIMMING;

ANIMALS; BEHAVIOR, ANIMAL; DARKNESS; LIGHT; LOCOMOTION; MALE; MICE; MICE, INBRED ICR; PHYSICAL CONDITIONING, ANIMAL; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 0031790034     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1998.20.7.485723     Document Type: Conference Paper

References (26)

1. Hatta, H. Treadmill running in rats and mice. Jpn J Biochem Exercise 1994. 7: 15-9.
2. Dawson, C.A., Horvath, S.M. Swimming in small laboratory animals. Med Sci Sports 1970, 2: 51-78.
3. Matsumoto, K., Ishihara, K., Tanaka., K. Inoue. K., Fushiki, T. An adjustable-current swimming pool for the evaluation of endurance capacity of mice. J Appl Physiol 1996, 81: 1843-9.
4. Porsolt. R.D., Le Pichon, M., Jalfre. M. Depression: A new animal model sensitive to antidepressam treatments. Nature 1977. 266: 730-2.
5. Porsolt, R.D., Bertin, A., Jalfre, M. Behavioral despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn 1977, 229: 327-36.
6. Borsini, F., Meli, A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 1988. 94: 147-60.
7. Wagemaker, H., Goldstein, L. The runner's high, J Sports Med 1980, 20: 227-9.
8. Mellion, M.B. Exercise therapy for anxiety and depression. Postgrad Med 1985, 77: 91-3.
9. Morgan, W.P. Affective beneficence of vigorous physical activity. Med Sci Sports Exere 1985, 17: 94-100.
10. Crawley, J., Goodwin, EK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 1980, 13: 167-70.
11. Costall, B., Hendrie, C.A., Kelly, M.E., Naylor, R.J. Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacol 1987. 26: 195-200.
12. Imaizuxni. M. Animal Models of anxiety based on exploratory behavior in rodents. Meth Find Exp Clin Pharmacol 1996, 18(A): 31-8.
13. Imaizumi, M., Suzuki, T., Machida, H.. Onodera, K. A fully automated apparatus for a light/dark test measuring anxiolytic or anxiogenic effects of drugs in mice. Jpn J Psychopharmacol 1994, 14: 83-91.
14. Gambert, S.R., Garthwaite, T.L., Pontzer, C.H. et al. Running elevates plasma β-endorphin immunareactivity and ACTH in untrained human subjects. Proc Soc Exp Biol Med 1981. 168: 1-4.
15. Haier, R.J., Quaid, K. Mills, J.S.C. Naloxone alters pain perception after jogging. Psychial Res 1981, 5: 231-2.
16. Henry, J.L. Circulating opioids: Possible physiological roles in central nervous function. Neurosci Behav Rev 1982, 6: 229-45.
17. Christie, M.J. Chesher, G.B. Physical dependence on physiologically released endogenous opiates. Life Sci 1982, 30: 1173-7.
18. Janal, M.N., Colt, E.W.D., Clark, W.C., Glusman, M. Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: Effects of naloxone. Pain 1984, 19: 13-25.
19. Tharp, G.D., Carson, W.H. Emotionality changes in rats following chronic exercise. Med Sci Sports 1975, 2: 123-6.
20. 1A receptor- and anxiety related behaviours. Neurosci Lett 1994, 176: 226-30.
21. MacNeil, G., Sela, Y., Maclntosh, J., Zacharko, M. Anxiogenic behavior in the light-dark paradigm following intraventricular administration of cholecystokinin-8S, restraint stress, or uncontrollable footshock in the CD-I mouse. Pharmacol Biochem Behav 1997, 58: 737-46.
22. Tejedor-Real, P., Mico, J.A., Maldonado, R., Roques. B.P. Gibert-Rahola, J. Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol Biochem Behav 1995, 52: 145-52.
23. Takahashi, M. Suppression by psychological stress of the development of morphine antinociceptive tolerance in mice. Meth Find Exp Clin Pharmacol 1996, 18(A): 67-73.
24. Yamauchi, N., Shibasaki. T., Wakabayashi, I., Demura, H. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat. Brain Res 1997, 777: 140-6.
25. Leslie, F.M. Methods used for the study of opioid receptors. Pharmacol Rev 1987, 39: 197-249.
26. Takemori, A.E., Portoghese, P.S. Selective naltrexonederived opioid receptor amagonists. Annu Rev Pharmacol Toxicol 1992, 32: 239-69.